Results 181 to 190 of about 1,561,985 (315)

Quality-Adjusted Life-Years Lost Due to COVID-19 Mortality: Methods and Application for The Netherlands. [PDF]

Value Health, 2022
Wouterse B, Ram F, van Baal P.
europepmc   +1 more source

Real-World Quality-Adjusted Life-Years Gains In Portuguese Patients with Rheumatoid Arthritis Following 1 Year of Golimumab Treatment [PDF]

, 2016
P.A. Laires, AF Mourão, Cristina Ribeiro, J. Borges, MJ Gonçalves, J P Bernardes, S. Fernandes, Raquel Dezerto, Mónica Eusébio, María José Santos, Helena Canhão   +10 more
openalex   +1 more source

PDB27 THE DIABETES PREVENTION PROGRAM (DPP) QUALITY OF WELL BEING (QWB) UTILITY MEASURES AND MISSING DATA CONSIDERATIONS: AVAILABLE CASE ANALYSIS (ACA) VS. MANSKI LOWER AND UPPER BOUNDS (LMB AND UMB) RESULTS FOR UTILITIES AND QUALITY ADJUSTED LIFE YEARS (QALYS) [PDF]

, 2020
P. Gebrehiwet, Tewodros Eguale, Alissa R. Segal, B Rittenhouse   +3 more
openalex   +1 more source

Phenotyping Healthcare Use 2–3 Decades Before the First Multiple Sclerosis Demyelinating Event

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Phenotype hospital, physician, and emergency department (ED) visits by diagnoses and specialty up to 29 years pre‐multiple sclerosis (MS) onset versus a matched population without MS. Methods We identified people with MS (PwMS) using population‐based administrative data from Ontario, Canada (1991–2020).
Helen Tremlett, Karl Everett, Colleen J. Maxwell, Feng Zhu, Ayesha Asaf, Ping Li, Kyla A. McKay, Yinshan Zhao, Ruth Ann Marrie   +8 more
wiley   +1 more source

PHL10 ASSESSING PATIENT PREFERENCES AND QUALITY-ADJUSTED LIFE YEARS (QALY) OF PROPHYLACTIC HAEMOPHILIA TREATMENT

, 2003
Birgit Schramm, Karin Berger, Uwe Siebert, Erik Berntorp, Paul Giangrande, Marijke van den Berg, W. Schramm   +6 more
openalex   +1 more source

Plasma microRNA Signature as Predictive Marker of Clinical Response to Therapy During Multiple Sclerosis

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Despite the availability of effective therapies for Multiple Sclerosis (MS), the unpredictable nature of disease progression and the variability in individual treatment outcomes call for reliable biomarkers. This pilot study aims to investigate the potential of plasma circulating microRNAs (miRNAs) as predictive biomarkers for ...
Fortunata Carbone, Alessandra Colamatteo, Teresa Micillo, Gianmarco Abbadessa, Silvia Garavelli, Clorinda Fusco, Claudia Russo, Francesco Perna, Federica Garziano, Claudia La Rocca, Maria Mottola, Giorgia Teresa Maniscalco, Simona Bonavita, Antonio Luca Spiezia, Alessia Castiello, Roberta Lanzillo, Vincenzo Brescia Morra, Claudio Procaccini, Paola de Candia, Giuseppe Matarese   +19 more
wiley   +1 more source

Making Rasch decisions: The use of Rasch analysis in the construction of preference based health related quality of life instruments [PDF]

Objective: To set out the methodological process for using Rasch analysis alongside traditional psychometric methods in the development of a health state classification that is amenable to valuation.
Brazier, J., Coyne, K., Tsuchiya, A., Yang, Y., Young, T.   +4 more
core   +3 more sources

Cost-utility tele-stroke in adults with acute ischemic stroke. A systematic review

Public Health in Practice
Introduction: Tele-Stroke has been proposed as a solution to increase access to thrombolytic therapy in acute ischemic stroke. Objective: Synthesise the evidence of the cost-effectiveness of Tele-Stroke.
Luis Alberto López-Romero, Dora Inés Parra, Alexandra Cortés Aguilar, Fabio Alberto Camargo Figuera   +3 more
doaj  

Potential of predictive computer models for preoperative patient selection to enhance overall quality-adjusted life years gained at 2-year follow-up: a simulation in 234 patients with adult spinal deformity [PDF]

, 2017
Tae-Min Oh, Justin K. Scheer, Justin S. Smith, Richard A. Hostin, Chessie Robinson, Jeffrey L. Gum, Frank J. Schwab, Robert A. Hart, Virginie Lafage, Douglas C. Burton, Shay Bess, Themistocles S. Protopsaltis, Eric O. Klineberg, Christopher I. Shaffrey, Christopher P. Ames, _ _   +15 more
openalex   +1 more source

Factors for Rituximab Refractoriness in AQP4‐IgG+ NMOSD: A Cohort Study

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Neuromyelitis optica spectrum disorder (NMOSD) is a severe autoimmune condition of the central nervous system (CNS), often associated with aquaporin‐4 antibodies (AQP4‐IgG). Rituximab, a CD20+ B‐cell depleting monoclonal antibody, is widely used as first‐line therapy.
Mariano Marrodan, María A. Piedrabuena, María A. Zarate, Sofía Rodríguez Murúa, Ezequiel I. Surace, Mauricio F. Farez, Marcela P. Fiol, María C. Ysrraelit, Jorge Correale   +8 more
wiley   +1 more source